Does free cell area influence the outcome in carotid artery stenting?

被引:240
作者
Bosiers, M.
de Donato, G.
Deloose, K.
Verbist, J.
Peeters, P.
Castriota, F.
Cremonesi, A.
Setacci, C.
机构
[1] AZ St Blasius, Dept Vasc Surg, B-9200 Dendermonde, Belgium
[2] Univ Siena, Dept Vasc & Endovasc Surg, I-53100 Siena, Italy
[3] Imelda Hosp, Dept Cardiovasc & Thorac Surg, Bonheiden, Belgium
[4] Villa Maria Cecilia Hosp, Intervent Cardioangiol Unit, Cotignola, RA, Italy
关键词
carotid artery stenting; carotid stenosis; neurological complications; cell design; free cell area; late embolic events;
D O I
10.1016/j.ejvs.2006.09.019
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objectives. To identify if carotid stent design, especially free cell area, impacts on the 30-day rates for stroke, death and TIA after carotid artery stenting (CAS). Material and methods. A CAS database of 3179 consecutive CAS patients was retrospectively assessed. The distribution Of neurological complications were analysed for association with the different stent types and designs. Events where subdivided into procedural and postprocedural events. Results. The overall combined rate of TIA, stroke and death was 2.8% at 30 days (late events 1.9%). The post-procedural event rate analyzed for differences stents varied from 1.2% using BSCI Carotid Wallstent to 5.9% using Medtronic Exponent. The late event rates varied from 1.2% to 3.4% for free cell areas < 2.5 mm(2) and > 7.5 mm(2) respectively (p < 0.05). Post-procedural event rate was 1.3% for closed cells and 3.4% for open cells. All these differences were highly pronounced among symptomatic patients (p < 0.0001). Conclusions. After carotid stenting, complication rates vary according to stent type, free cell area and cell design. In the symptomatic population (and also in the total population), post-procedural complication rates are highest for the open cell types and increase with larger free cell area.
引用
收藏
页码:135 / 141
页数:7
相关论文
共 30 条
[1]   Long-term results of carotid stenting are competitive with surgery [J].
Bergeron, P ;
Roux, M ;
Khanoyan, P ;
Douillez, V ;
Bras, J ;
Gay, J .
JOURNAL OF VASCULAR SURGERY, 2005, 41 (02) :213-221
[2]   Carotid plaque echolucency increases the risk of stroke in carotid stenting - The Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS) study [J].
Biasi, GM ;
Froio, A ;
Diethrich, EB ;
Deleo, G ;
Galimberti, S ;
Mingazzini, P ;
Nicolaides, AN ;
Griffin, M ;
Raithel, D ;
Reid, DB ;
Valsecchi, MG .
CIRCULATION, 2004, 110 (06) :756-762
[3]   Carotid artery stenting: Which stent for which lesion? [J].
Bosiers, M ;
Deloose, K ;
Verbist, J ;
Peeters, P .
VASCULAR, 2005, 13 (04) :205-210
[4]  
Bosiers M, 2005, J CARDIOVASC SURG, V46, P241
[5]  
Bosiers M, 2003, J ENDOVASC THER, V10, P695, DOI 10.1583/1545-1550(2003)010<0695:BEWFEI>2.0.CO
[6]  
2
[7]   Outcome of carotid stenting versus endarterectomy - A case-control study [J].
Cao, P ;
De Rango, P ;
Verzini, F ;
Maselli, A ;
Norgiolini, L ;
Giordano, G .
STROKE, 2006, 37 (05) :1221-1226
[8]   Carotid endarterectomy for asymptomatic carotid stenosis [J].
Chambers, B. R. ;
Donnan, G. A. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (04) :11-20
[9]   Protected carotid stenting - Clinical advantages and complications of embolic protection devices in 442 consecutive patients [J].
Cremonesi, A ;
Manetti, R ;
Setacci, F ;
Setacci, C ;
Castriota, F .
STROKE, 2003, 34 (08) :1936-1941
[10]  
CREMONESI A, 2006, STROKE 0810